Rebecca Burnau
Nurse Practitioner · Benton Harbor, MINPI 1538482237
Payments from drug & device makers
Across 107 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$579
- Neurocrine Biosciences, Inc.$333
- Johnson & Johnson$278
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$259
- Vanda Pharmaceuticals Inc.$246
- Alkermes, Inc.$200
- plus $647 from 9 others
What the payments were for
- Food & beverage$2,11383%
- Education$42917%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $579 |
| Neurocrine Biosciences, Inc. | 17 | $333 |
| Johnson & Johnson | 12 | $278 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $259 |
| Vanda Pharmaceuticals Inc. | 11 | $246 |
| Alkermes, Inc. | 10 | $200 |
| E.r. Squibb & Sons, L.L.C. | 6 | $182 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| AbbVie | 5 | $91 |
| Indivior Inc. | 4 | $91 |
| Axsome Therapeutics, Inc. | 2 | $79 |
| Lundbeck LLC | 3 | $50 |
| Eisai Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
How this compares
$2,543 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 101 | $328,543 |
| AustedoDeutetrabenazine | 35 | $320,438 |
| Abilify MaintenaAripiprazole | 87 | $238,134 |
| FanaptIloperidone | 69 | $118,892 |
| IngrezzaValbenazine Tosylate | 13 | $101,358 |
| Paliperidone ErPaliperidone | 102 | $18,201 |
| Clozapine | 101 | $14,890 |
| Chlorpromazine Hcl | 76 | $12,774 |
| Haloperidol Decanoate | 234 | $12,655 |
| Divalproex Sodium ErDivalproex Sodium | 156 | $12,068 |
| Quetiapine Fumarate | 370 | $9,677 |
| Haloperidol | 217 | $8,352 |
| Risperdal ConstaRisperidone Microspheres | 24 | $8,216 |
| Olanzapine | 227 | $7,426 |
| Divalproex Sodium | 133 | $7,308 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $278 | $336,758125 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $579 | $320,43835 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $98 | $238,13487 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $246 | $118,89269 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $333 | $101,35813 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $19 | $7,22415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Benton Harbor
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.